إعلان
إعلان
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
15.02
USDبرعاية
-0.58
-3.74%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
15.49
+0.48
+3.19%
تقارير أرباح PHAT
النسبة الإيجابية المفاجئة
PHAT تفوق 14 من 25 آخر التقديرات.
56%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$57.08M
/-$0.39
التغير الضمني من Q3 25 (Revenue/ EPS)
+15.31%
/-4.88%
التغير الضمني من Q4 24 (Revenue/ EPS)
+92.43%
/-62.86%
Phathom Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٣٠ أكتوبر ٢٠٢٥, PHAT reported earnings of -0.41 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 26.25% surprise. Revenue reached 49.50 مليون, compared to an expected 47.93 مليون, with a 3.28% difference. The market reacted with a -1.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of -0.39 USD, with revenue projected to reach 57.08 مليون USD, implying an نقصان of -4.88% EPS, and زيادة of 15.31% in Revenue from the last quarter.
الأسئلة الشائعة
What were Phathom Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Phathom Pharmaceuticals, Inc. Common Stock reported EPS of -$0.41, beating estimates by 26.25%, and revenue of $49.50M, 3.28% above expectations.
How did the market react to Phathom Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.63%, changed from $13.53 before the earnings release to $13.31 the day after.
When is Phathom Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for Phathom Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 11
المحللين, Phathom Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.39 and revenue of $57.08M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان